Fig. 2 | Scientific Reports

Fig. 2

From: Identification of a super enhancer associated gene signature for the prognosis prediction and regulatory mechanism exploration in breast cancer

Fig. 2The alternative text for this image may have been generated using AI.

Construction and validation of a clinical nomogram. (A) Time-dependent receiver operating characteristic (tROC) curves of the SERS in predicting the 1-, 3-, 5- and 10-year OS; (B) Univariate Cox regression analysis of SERS and clinical characteristics; (C) Multivariate Cox regression analysis of SERS and clinical characteristics; (D) Nomogram based on the SERS, age and lymph node status; (E) Time-dependent ROC curves of the nomogram in predicting the 1-, 3-, 5- and 10-years OS in the training cohort; (F) Calibration curves of the nomogram in predicting the 1-, 3-, 5- and 10-years OS in the training cohort; (G) Time-dependent ROC curves of the nomogram in predicting the 1-, 3-, 5- and 10-years OS in the validation cohort; (H) Calibration curves of the nomogram in predicting the 1-, 3-, 5- and 10-years OS in the validation cohort. AUC, area under curve; HR: hazard ratio; CI: confidence interval; SERS, super enhancer-related score; OS, overall survival.

Back to article page